215 related articles for article (PubMed ID: 11788654)
1. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.
Vella V; Pandini G; Sciacca L; Mineo R; Vigneri R; Pezzino V; Belfiore A
J Clin Endocrinol Metab; 2002 Jan; 87(1):245-54. PubMed ID: 11788654
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
[TBL] [Abstract][Full Text] [Related]
3. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
[TBL] [Abstract][Full Text] [Related]
5. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
[TBL] [Abstract][Full Text] [Related]
7. The IGF system in thyroid cancer: new concepts.
Vella V; Sciacca L; Pandini G; Mineo R; Squatrito S; Vigneri R; Belfiore A
Mol Pathol; 2001 Jun; 54(3):121-4. PubMed ID: 11376121
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain.
Denley A; Brierley GV; Carroll JM; Lindenberg A; Booker GW; Cosgrove LJ; Wallace JC; Forbes BE; Roberts CT
Endocrinology; 2006 Feb; 147(2):1029-36. PubMed ID: 16239300
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.
Belfiore A; Frasca F; Pandini G; Sciacca L; Vigneri R
Endocr Rev; 2009 Oct; 30(6):586-623. PubMed ID: 19752219
[TBL] [Abstract][Full Text] [Related]
13. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
[TBL] [Abstract][Full Text] [Related]
14. 'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors.
Rikhof B; van der Graaf WT; Suurmeijer AJ; van Doorn J; Meersma GJ; Groenen PJ; Schuuring EM; Meijer C; de Jong S
Am J Pathol; 2012 Jul; 181(1):303-12. PubMed ID: 22658485
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
[TBL] [Abstract][Full Text] [Related]
16. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
Vella V; Malaguarnera R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513575
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
19. Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.
Belfiore A; Pandini G; Vella V; Squatrito S; Vigneri R
Biochimie; 1999 Apr; 81(4):403-7. PubMed ID: 10401676
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
Brierley GV; Macaulay SL; Forbes BE; Wallace JC; Cosgrove LJ; Macaulay VM
Endocrinology; 2010 Apr; 151(4):1418-27. PubMed ID: 20179263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
